TRIMO-SAN- oxyquinoline sulfate and sodium lauryl sulfate jelly 
Denison Pharmaceuticals, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Trimo San

CONTENTS

Hydroxyquinoline Sulfate 0.025%; Sodium Lauryl Sulfate N.F. 0.01%. Adjusted with Triethanolamine to pH 4 in water dispersible base composed of Glycerine, Carbomer N.F., Citric Acid, Sodium Citrate U.S.P., Methylparaben N.F., Perfume and Antifoam Emulsion N.F.

STORAGE:

AFTER EACH USE Wipe threads of tube and the inside of the cap. RE-CAP TIGHTLY. Store at room temperature.

TRIMO-SAN and PREGNANCY

TRIMO-SAN has NOT been tested for use during pregnancy.

GENERAL INFORMATION

Use Cap to pierce seal in head of tube

Instructions for use inside package

Keep this product out of the reach of children

PRINCIPAL DISPLAY PANEL

label

TRIMO-SAN 
oxyquinoline sulfate and sodium lauryl sulfate jelly
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0295-5030
Route of AdministrationVAGINAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYQUINOLINE SULFATE (UNII: 61VUG75Y3P) (OXYQUINOLINE - UNII:5UTX5635HP) OXYQUINOLINE0.25 mg  in 1 g
SODIUM LAURYL SULFATE (UNII: 368GB5141J) (LAURYL SULFATE - UNII:DIQ16UC154) SODIUM LAURYL SULFATE0.1 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
TROLAMINE (UNII: 9O3K93S3TK)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
CARBOMER 934 (UNII: Z135WT9208)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0295-5030-18113.4 g in 1 TUBE; Type 0: Not a Combination Product09/16/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/16/2019
Labeler - Denison Pharmaceuticals, LLC (001207208)
Establishment
NameAddressID/FEIBusiness Operations
Denison Pharmaceuticals, LLC001207208manufacture(0295-5030)

Revised: 9/2019
Document Id: 9249c02c-05b5-5fb2-e053-2a95a90a2b2b
Set id: 9249da53-e62c-bb0c-e053-2995a90a8d5a
Version: 1
Effective Time: 20190911
 
Denison Pharmaceuticals, LLC